CONMED Corporation (CNMD)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$49.32-0.20%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · CNMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 1,371.7 | 1,374.7 | 1,307.0 | 1,244.7 | 1,045.5 | 1,010.6 | 862.5 | 955.1 | 859.6 | 796.4 | 763.5 | 719.2 | 740.1 | 762.7 | 767.1 | 725.1 |
| Total Revenues | 1,371.7 | 1,374.7 | 1,307.0 | 1,244.7 | 1,045.5 | 1,010.6 | 862.5 | 955.1 | 859.6 | 796.4 | 763.5 | 719.2 | 740.1 | 762.7 | 767.1 | 725.1 |
| Cost of Revenues | 606.3 | 624.2 | 574.0 | 568.5 | 474.2 | 442.6 | 402.2 | 430.4 | 390.5 | 365.4 | 355.2 | 337.5 | 336.0 | 350.3 | 361.3 | 350.1 |
| Gross Profit | 765.3 | 750.5 | 733.0 | 676.2 | 571.2 | 568.0 | 460.3 | 524.7 | 469.1 | 431.0 | 408.3 | 381.7 | 404.1 | 412.4 | 405.8 | 374.9 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 594.4 | 592.0 | 478.3 | 503.0 | 454.0 | 414.8 | 373.8 | 400.1 | 355.6 | 351.8 | 338.4 | 303.1 | 323.5 | 330.1 | 302.5 | 276.6 |
| R&D Expenses | 60.6 | 55.9 | 54.4 | 52.6 | 47.2 | 43.6 | 40.5 | 45.5 | 42.2 | 32.3 | 32.3 | 27.4 | 27.8 | 25.8 | 28.2 | 28.7 |
| Operating Income | 110.3 | 102.6 | 200.3 | 120.6 | 70.1 | 109.7 | 46.0 | 79.1 | 71.3 | 46.9 | 37.7 | 51.2 | 52.8 | 56.5 | 65.2 | 8.3 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 29.9 | 31.1 | 37.3 | 39.8 | 28.9 | 35.5 | 44.1 | 42.7 | 20.7 | 18.2 | 15.4 | 6.0 | 6.1 | 5.6 | 5.7 | 6.7 |
| EBT, Incl. Unusual Items | 83.2 | 71.1 | 163.0 | 80.8 | (70.9) | 73.1 | 1.6 | 31.2 | 50.7 | 28.7 | 19.4 | 45.1 | 46.7 | 50.6 | 59.5 | (2.3) |
| Income Tax Expense | 26.7 | 24.1 | 30.6 | 16.4 | 9.7 | 10.6 | (7.9) | 2.6 | 9.8 | (26.8) | 4.7 | 14.6 | 14.5 | 14.7 | 19.0 | (3.1) |
| Net Income | ||||||||||||||||
| Net Income | 56.5 | 47.1 | 132.4 | 64.5 | (80.6) | 62.5 | 9.5 | 28.6 | 40.9 | 55.5 | 14.7 | 30.5 | 32.2 | 35.9 | 40.5 | 0.8 |
| Per Share | ||||||||||||||||
| Basic EPS | 1.88 | 1.52 | 4.29 | 2.10 | (2.68) | 2.14 | 0.33 | 1.01 | 1.45 | 1.99 | 0.53 | 1.10 | 1.17 | 1.30 | 1.43 | 0.03 |
| Diluted EPS | 1.88 | 1.51 | 4.25 | 2.04 | (2.68) | 1.94 | 0.32 | 0.97 | 1.41 | 1.97 | 0.52 | 1.09 | 1.16 | 1.28 | 1.41 | 0.03 |
| Revenue per Share | 45.54 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.60 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.65 | 0.60 | — |
| Basic Weighted Avg Shares | 30.1 | 31.0 | 30.8 | 30.7 | 30.0 | 29.2 | 28.6 | 28.3 | 28.1 | 27.9 | 27.8 | 27.7 | 27.4 | 27.7 | 28.3 | 28.2 |
| Diluted Weighted Avg Shares | 30.1 | 31.1 | 31.2 | 31.5 | 30.0 | 32.2 | 29.5 | 29.5 | 28.9 | 28.2 | 28.0 | 27.9 | 27.8 | 28.1 | 28.7 | 28.6 |
| Supplemental | ||||||||||||||||
| EBIT | 110.3 | 102.6 | 200.3 | 120.6 | 70.1 | 109.7 | 46.0 | 79.1 | 71.3 | 46.9 | 37.7 | 51.2 | 52.8 | 56.5 | 65.2 | 8.3 |
| Effective Tax Rate | 32.1% | — | — | 20.3% | -13.7% | 14.4% | -493.7% | 8.3% | 19.3% | -93.1% | 24.3% | 32.4% | 31.0% | 29.0% | 31.9% | 132.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.